Acral cutaneous malignant melanoma treated with linear accelerator-based boron neutron capture therapy system: a case report of first patient

Acral cutaneous malignant melanoma treated with linear accelerator-based boron neutron capture therapy system: a case report of first patient

This study reports the first patient treatment for cutaneous malignant melanoma using a linear accelerator-based boron neutron capture therapy (BNCT) system. A single-center open-label phase I clinical trial had been conducted using the system since November 2019. A patient with a localized node-neg...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Hiroshi Igaki, Satoshi Nakamura, Naoya Yamazaki, Tomoya Kaneda, Mihiro Takemori, Tairo Kashihara, Naoya Murakami, Kenjiro Namikawa, Tetsu Nakaichi, Hiroyuki Okamoto, Kotaro Iijima, Takahito Chiba, Hiroki Nakayama, Ayaka Nagao, Madoka Sakuramachi, Kana Takahashi, Koji Inaba, Kae Okuma, Yuko Nakayama, Kazuaki Shimada, Hitoshi Nakagama, Jun Itami
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Frontiers Media S.A. 2023-10-01
Saila:Frontiers in Oncology
Gaiak:
boron neutron capture therapy (BNCT)
malignant melanoma
linear accelerator-based BNCT system
solid-state Li target
acral malignant melanoma
first treatment
Sarrera elektronikoa:https://www.frontiersin.org/articles/10.3389/fonc.2023.1272507/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1272507/full

Antzeko izenburuak